Elidel (Pimecrolimus) - Drug Interactions, Contraindications, Overdosage

DRUG INTERACTIONS

Drug Interactions

Potential interactions between ELIDEL and other drugs, including immunizations, have not been systematically evaluated. Due to low blood levels of pimecrolimus detected in some patients after topical application, systemic drug interactions are not expected, but cannot be ruled out. The concomitant administration of known CYP3A family of inhibitors in patients with widespread and/or erythrodermic disease should be done with caution. Some examples of such drugs are erythromycin, itraconazole, ketoconazole, fluconazole, calcium channel blockers and cimetidine.

OVERDOSAGE

There has been no experience of overdose with ELIDEL ^® (pimecrolimus) Cream 1%. If oral ingestion occurs, medical advice should be sought.

CONTRAINDICATIONS

ELIDEL ^® (pimecrolimus) Cream 1% is contraindicated in individuals with a history of hypersensitivity to pimecrolimus or any of the components of the cream.